Open to all in the veterinary profession, the event offers up to ten hours of CPD, and covers a range of topics such as orthopaedics, ECC, medicine, wellbeing, and education.
There will also be practical sessions to attend on both days on transfusions, CPR, and physio.
Speakers include:
There's a commercial exhibition, and social events including the Ceilidh at the annual BSAVA PetSavers Gala Dinner on Friday evening.
Prices start at £85 +VAT for a day pass, with early bird rates offered to both BSAVA members and non-members until 27th July.
Additional discounts are available when sending the whole practice team.
https://www.bsavaevents.com/bsavaalba23/en/page/home
The ‘Midgeater' device introduced by Calor in 2003 to combat biting midges causing irritation to humans, has now been successfully tested by leading scientists as a monitoring device in the fight against bluetongue.
Leading midge scientist Dr Alison Blackwell, who is the Managing Director of University of Edinburgh based Advanced Pest Solutions, presented her company's findings in her keynote speech to the Royal Entomological Society in Belfast on November 19th.
The current method of trapping midges when monitoring the deadly bluetongue virus is a light trap, but Alison and her team have established that a modified Midgeater can be more effective in catching the main midge species that carry the virus.
Alison said: "During trials this year, we found that Calor fuelled Midgeater traps modified with a simple ‘black' light source and fitted with an octenol / ammonia bait, proved to be far more effective at catching the main species of midge known to carry the bluetongue virus than the light traps which are currently used to monitor midge populations in relation to the disease".
Farmers throughout the UK recently commenced a vaccination programme to protect their animals from the only strain of the bluetongue virus that has so far been encountered in the UK, serotype 8, but there is still a real need to carefully monitor biting midge populations, as other strains of the virus are approaching our shores.
Alison added: "In the last few weeks serotype 1 and serotype 6 have been found in Northern Europe and there are currently no vaccines available in the UK for these types of the bluetongue virus, so it is important that we remain vigilant and monitor midges throughout the UK".
Advanced Pest Solutions have tested their modified Midgeater traps in England and Wales. The English, project which was carried out at a specialist bull breeding facility, also included the use of the Barrfly air curtain, from fellow Scottish business Innovent.
Alison explained: "Innovent's air curtain is designed to prevent midges passing through it into sensitive areas. The insects simply aren't strong enough to fly through the air currents it produces.
"The air curtain, combined with the Calor supplied traps and APS's consultancy and analysis creates a comprehensive ‘assess, protect and stop', midge management system that businesses can use to reduce the exposure to the risks of midge borne diseases."
Supreme Petfoods Ltd has published the results of tests on small animal petfood which, according to the company, highlight significant problems with the on-pack declarations and contents of a number of the leading brands.
The tests, which were carried out by Campden BRI on behalf of Supreme Petfoods, discovered:
Issues regarding high sugar levels which are not required to be declared under current rules. The highest average levels of sugar were found in Wagg Optimum (4.57%), Beaphar Care + (5.00%), Burgess Supa Fruiti (5.10%), Beaphar Extra Vital (5.35%) and Burgess Excel (4.04%).
In the company's press release, Chris Childs, Managing Director of Supreme Petfood, commented: "The results greatly concerned us. We were shocked to find food that is marketed for rabbits - ie: herbivores - had traces of mammalian and avian DNA in it. In my opinion, this can only be compared to vegetarian food being contaminated with meat. This was our main concern amongst many other issues revealed."
That strikes me as overstating the case somewhat. Aside from the fact that bunnies don't get quite as het up about their diets as vegans, the report does not define what 'trace DNA contamination is'. Going on the shock expressed by Mr Childs, I'm expecting a pork chop or a drumstick in every bag of Burgess Excel at the very least.
Molly Varga, BVetMed, DZooMed (Mammalian), MRCVS told VetSurgeon.org that she would expect rabbits to be exposed to trace amounts of animal DNA naturally and that the amounts found in the tests were not likely to have any effect whatsoever on the health of rabbits. Nevertheless, she did feel that the report highlighted important issues concerning the fibre and sugar content of various diets.
As a consequence of the report, Supreme Petfoods is calling for an overhaul of the rules and regulations which apply to pet food for small companion animals. The company suggests the introduction of an accredited quality scheme aimed specifically at pet food for small companion animals, containing strict conditions for the production, packaging and marketing of food for herbivores.
In response, Burgess Pet Care issued a statement expressing considerable reservations as to the timing, purpose and potential negative outcome for the welfare of pet rabbits of Supreme's report. Commenting on behalf of Burgess, Sharon Redrobe, Head of Veterinary Services, Bristol Zoo Gardens, and Head of Rabbit Clinic, Bristol, said: "Any research into small animal health should focus on the crucial role of fibre in a balanced feeding plan and how this can be communicated to rabbit owners, so discussions centring around the detailed contents of pellets are irrelevant in my opinion to this central welfare issue."
To read Supreme's report, click here.
The campaign comprises of a series of live interviews, articles and surveys aimed at exploring the impact of breast cancer, menopause, infertility and baby loss women, and men, and how the veterinary profession can better support people having to cope with these issues in the workplace.
The campaign includes free access articles and live online sessions with VetYourBreasts campaign organiser, veterinary surgeon Anna Beber, as part of Breast Cancer Awareness Month; VetMINDS co-founder, vet Nat Scroggie, on 12th October during Baby Loss Awareness Week; Dr Karen Morton, consultant obstetrician and gynaecologist on World Menopause Day 18th October; and SPVS Senior Vice President, Catriona Curtis, talking about her personal experiences with infertility on 2nd November during National Fertility Week.
A survey on the impact of the menopause, particularly on working life, is being run in partnership with SPVS in the run up to World Menopause Day. The survey seeks to gain a broad understanding of both awareness and experience across the profession, and responses are encouraged from all ages and genders, whether personally affected or not. The survey can be accessed here until 15th October: https://bit.ly/2FVXIkv
SPVS President, Anna Judson, said: "Having experienced the effects of the menopause working as a practice owner, I wish I had known more about the impact and that I was not alone in how I was feeling. There is a growing appetite to tackle these issues and we want to hear from anyone affected by the menopause, in order to put the right support mechanisms in place. We're proud to sponsor the menopause webinar and partner with Veterinary Woman on raising awareness about health issues, which are often brushed under the carpet."
Liz Barton, editor of Veterinary Woman, said: "I have been incredibly moved to see the deep empathy and encouragement amongst veterinary colleagues beginning to open up about the impact of health challenges, particularly at work. When I realised the campaigns in October were topics we need to talk about more as a profession, it seemed right to use this as a platform to tackle some of the hidden, emotive health challenges we bear throughout our life and work. We are looking for partners to help us develop the conversations and practical assistance for individuals and practices, to better support those who are silently living with these burdens."
Companies and organisations wishing to support the work should contact liz@veterinarywoman.co.uk. Individuals can register for updates about how to access the sessions by joining the Veterinary Woman email list for updates (www.veterinarywoman.co.uk), or following Veterinary Woman on social media.
The 10 minute survey seeks to capture the current level of understanding and feelings around the deployment of AI tools across the veterinary industry.
VetCT says the purpose of the survey is to start some discussion and identify areas where training and support could help veterinary practitioners.
Julien Labruyère, Chief Innovation Officer at VetCT (pictured), said: “AI is here to stay and will increasingly become part of all aspects of veterinary medicine.
"Indeed, it’s vital to help us solve some of the workforce pressures the profession is facing globally.
"We will increasingly be using the outputs of AI tools to inform our clinical decisions, and yet the mechanisms and algorithms can be something of a black box of mystery.
“We want to understand the needs of clinicians in understanding how to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"The results will be published and freely accessible.
"Our hope is to encourage a collaborative effort to support veterinary teams with embracing the full potential of AI, yet also providing the safeguards and education to the clinicians applying this technology to their patients.”
The survey is here: https://bit.ly/VetCT_AI_Survey.
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
The UK's first online gastric ulcer risk assessment for horse owners has just been launched as part of the 2009 Gastric Ulcer Awareness Month (GUAM), organised by Merial Equine Health.
Merial has developed the risk online questionnaire to enable owners to evaluate their horse's risk of ulcers. By logging on to the website http://www.gastriculcerrisk.co.uk/, owners, trainers and riders can complete a form which then returns the results via email. Where an animal is considered to be at medium to high risk, owners will be advised to consult their veterinary practice.
The company's Dr Emma Batson said: "Since the first GUAM in 2007, significant progress has been made in developing awareness and understanding of equine gastric ulcer syndrome.
"However there is still more to do! Our goal is to move gastric ulcers further up the diagnostic process, such that the condition is an early consideration for all horses presented with the vague symptoms associated with ulceration. We know that due to the vague nature of the symptoms, many of horses are suspected of other ailments such as back and teeth problems, general poor performance, or behavioural issues prior to being diagnosed with ulcers.
"This new initiative has been developed through consultation with practising internal medicine specialists. We hope it will help to highlight more cases and encourage clients into the practice with horses that are at genuine risk of ulcers. Further diagnosis, treatment and management measures can then be considered in consultation with the client.
"The website also has a veterinary page so that follow up information and any gastroscopy results can be recorded by the vet. We hope that this feedback will help generate some valuable data for the industry."
To help you promote this initiative, Merial has produced an impactful poster for use in practice waiting rooms, along with educational literature. The poster will be available as a loose insert in various publications during April and May.
For those practices which require a referral scoping service, Merial can put you in touch with three specialist consultants; Rachael Conwell (North) Dr.Tim Brazil (Midlands/nationwide) and Richard Hepburn (South West) who each provide a mobile scoping clinic.
Merial is also promising support for the mobile scoping service for the five practices that direct the largest number of clients to http://www.gastriculcerrisk.co.uk/
A number of events are also taking place during the month for vets, trainers and horse owners, including the following CPD events:
GUAM is supported by BEVA and Dr Batson hopes that the 2009 initiatives will further boost awareness, understanding and diagnosis of this underrated condition.
Vetoquinol UK Ltd has launched a new flea and tick treatment for cats and dogs.
Flevox is a spot-on solution containing fipronil and comes in unique pack sizes of either single pipettes or large clinic packs of 36.
Product Manager Helen Walker said: "With only 55% of pet owners buying their flea and tick treatment from the vet, we recognise there is a huge opportunity to develop and grow this essential market. In the modern age the consumer expects maximum flexibility, and that is what we aim to provide with Flevox.
Whether it be persuading the price-conscious customer away from buying their flea treatments in supermarkets and the internet, or encouraging those who don't treat their pet at all to give it a try without breaking the bank, we're confident we can help grow flea treatment sales in practice."
Vetoquinol says it is supporting the new product with a range of materials dedicated to veterinary surgeries, providing incentives to encourage client bonding and repeat business with your practice.
Helen continued: "We have also teamed up with the fantastic charity Dogs for the Disabled by making a donation for every pipette of Flevox sold. We're really looking forward to raising the profile of this organisation where these amazing dogs give life changing independence to disabled people. We're confident the donation will strike a chord with clients and really engage them with the charity, the Flevox brand and the practice".
To find out more, contact your Vetoquinol territory manager or visit http://www.vetoquinol.co.uk/
Vétoquinol, the makers of Zylkène, is offering the chance for a veterinary professional to receive a bursary towards the Centre of Applied Ethnology (COAPE) Behaviour Diploma, worth £5000.
The company says behavioural training offers a wealth of benefits to veterinary practices and staff, including safer pet handling, improved client loyalty and a more comfortable environment for animals, as well as the opportunity to help increase the clinic's income.
The COAPE Behaviour Diploma is designed to help professionals further their knowledge of behavioural issues and gives them the skills to deal with situations that may arise during the course of their work. It is broken down into 3 one-year-long courses, each costing £5000.
Jodie Foster of Haygate Vets in Telford was the recipient of last year's bursary and has since been voted the VN Times Welfare Nurse of the Year. She said: "I'd been interested in doing this course for some time, so it was amazing to hear that I'd been selected. I have found it challenging at times, but it's also been very rewarding and has really helped to improve my confidence when dealing with behavioural situations at work.
"The course tutors were fantastic and really fuelled my desire to further develop my knowledge of animal behaviour. The course definitely contributed to being awarded the prize from VN Times so I would strongly recommend that anyone with an interest in pet behaviour applies for the bursary."
To apply, complete the application form at www.zylkenepet.co.uk/COAPE by 10 August 2014, explaining why you want to further your knowledge of animal behaviour and what you hope to achieve on completing the course.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The recommendation follows the analysis of data collected as part of the company's Talk About Laminitis disease awareness initiative, which has seen more than 47,000 horses tested for PPID since it was launched in 20121.
The data revealed that, regardless of presenting clinical signs, a horse aged 15-20 is three times more likely to have PPID compared to a horse under 10, and this risk increases with age. For example, a horse of 20-25 is six times more likely to have PPID compared to a horse under 10 and a horse that is 25-30 is 10 times more likely to have PPID.
Boehringer says that despite the high prevalence of PPID in the older horse population, the clinical signs of the disease are insidious in onset and owners may simply associate them with the ageing process.
One study demonstrated that in a single population of horses over the age of 15 only 1.6% of owners reported signs of PPID2. However, when the same group of horses were examined by a veterinary surgeon, 21% were found to have signs of the disease.
Dr Jo Ireland, veterinary surgeon at the University of Liverpool, said: "It is often difficult for owners to spot the signs of PPID as they frequently associate them with the ageing process. However, PPID is now the fifth most commonly diagnosed disease in horses in the UK3.
"We are therefore encouraging veterinary surgeons to routinely test horses over 15 years of age or those that are displaying signs of PPID with an ACTH test."
The 'Talk About Laminitis' disease awareness initiative runs from June until the end of October and aims to raise awareness of the underlying hormonal causes of laminitis – PPID and Equine Metabolic Syndrome (EMS). As part of the scheme, the laboratory fees for the blood test which detects PPID (the basal ACTH test) are free.
Redwings’ head of veterinary and care, senior veterinary surgeon Nicky Jarvis, said: "Any initiative that decreases the incidence of laminitis developing in an older equine is invaluable. Laminitis is an extremely distressing condition for both the horse and the owner and the long-term consequences can be devastating. Knowing the underlying cause is a huge help in tackling the disease and we would encourage anyone to take advantage of this offer and get their veteran checked out."
For further information about 'Talk About Laminitis', visit www.talkaboutlaminitis.co.uk or contact your local Boehringer Ingelheim account manager.
References
Normally only accessible by ISFM members, the channel has been opened up as a free resource to help vets keep on top of CPD and includes over 40 webinars presented by internationally recognised veterinary specialists.
Topics include: anaesthesia and analgesia, behaviour, emergency and critical care, feline medicine and neurology. Each webinar is worth 1 hour of CPD and you get a certificate.
The channel includes a new webinar: ‘COVID-19 – helping cats cope’ which looks at how you can advise owners to help their cats deal with changes at home.
ISFM’s Feline Medicine Consultant, Sam Taylor said: "ISFM is committed to educating veterinary professionals on all things feline, so we are delighted to be able to bring some of our normally member-only benefits to a wider audience during this challenging time."
To register for the ISFM webinar channel, visit: https://icatcare.org/event/isfm-vet-webinars/
In particular, the association says it is looking for people with expertise in the following areas:
VMG President Rich Casey (pictured right) said: “During the last two years alone, we have launched a new suite of ILM-accredited Award in Veterinary Leadership and Management (AVLM) qualifications, together with our evidence-based Leadership Standards Framework.
"We have also announced our intent to support the specific needs of our members more closely through our own congress and other initiatives, as well as helping to guide the wider veterinary profession through the challenges and opportunities that lie ahead.
“We’re proud of what we have achieved so far but we have much more to do.
'We are looking for several new directors with specific skills to help us offer the highest level of support we can to our members in 2023 and beyond.”
The deadline for applications is 3 October 2022.
https://vetmg.com/vmg-new-director-search
According to today's Daily Mail, veterinary surgeon Lis Crowsley may have been killed as she tried to protect her dogs from cows that were with their newly-born calves.
Click here for the full story.
Pfizer VPS has launched a 'Pre-Sale Scab Treatment Certificate' so that sheep treated for sheep scab and protected against re-infestation beyond their autumn sale date can be formally certified as such.
A choice of two moxidectin-based treatments are eligible for use, one with 28 days and the other 60 days licensed persistency against the scab mite.
Pfizer VPS vet David Bartram explained that following treatment, the sale date must fall within the persistency window: "The idea is that farmers present their certificate at markets on sale day, then auctioneers announce the scab-protected status during their sales patter. Whether this adds to the sale price will be interesting to find out, but it's sure to be seen as a valuable attribute by buyers who won't need to treat for scab when they arrive home."
Details of the certification process are available from SQPs at animal medicine suppliers. The two eligible treatments are CYDECTIN 1% LA and CYDECTIN 2% LA for sheep.
Pfizer's Vet Support+ has launched the Practice Management Academy, which offers online training in the key management disciplines required to run a successful veterinary business.
There are twelve courses which cover four key areas of management: financial operations, staff management, client relations and marketing. Participants can choose to study individual courses, a specific area of management, or enrol in the full Practice Management Academy.
The courses are four weeks in length and contribute up to ten hours of CPD learning through a mix of interactive activities, case studies, questions and a student learning forum.
Each course is also allocated a Pfizer Business Consultant to work as an online expert tutor, posing questions and stimulating forum discussion amongst the students.
Pfizer says that the significant cost saving e-learning represents over external CPD is making the Academy a popular choice for all members of the practice team, especially those who may be taking on new management responsibilities or those looking for a refresher. According to the company, one large vet group has already taken twenty places on each of the courses to improve the practice management skills across its extensive team.
Ned Flaxman, Director Business Innovation said: "Using an E-Learning platform is a well-trodden path, ideal for busy individuals wishing to improve or gain new practice management skills without leaving the surgery, or sofa. However, unlike some e-learning which can leave the participant feeling like they are gaining theoretical know-how only, and working in somewhat of a silo, our Academy offers an 'online campus'. This provides a flexible, convenient and supportive training environment for shared theory and practical learning with other colleagues from the veterinary profession under the guidance of e-tutors and experts."
For further details visit http://www.vetsupportplus.co.uk/
New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
Petplan has announced the winners of its annual Veterinary Awards.
The awards recognise and celebrate staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Isabella von Mesterhazy, Petplan's Head of Marketing, said: "As the leader in the pet insurance market for over 35 years, we have a rich history of working with veterinary practices across the UK. The Veterinary Awards is a great way to celebrate the fantastic work that goes on helping keep pets healthy and their owners happy."
She added: "This year saw over 11,000 nominations which goes to show the appetite from both staff and clients for celebrating exceptional work. We had an outstanding selection of finalists and I'd like to congratulate all the winners who thoroughly deserve their awards."
The winners for each category are:
VET OF THE YEAR - Laura Pugh, Ashfield House Veterinary Hospital - Long Eaton, NottinghamWhat really stood out was Laura's willingness to go above and beyond the call of duty. As well as Laura's stressful day job she is very involved with the local community. Laura writes an animal column in her local neighbourhood magazine, runs evening talks on a variety of subjects and visits local schools.
VET NURSE OF THE YEAR - Catherine Raw, Broadleys Veterinary Hospital - Stirling, ScotlandCatherine's passion for her role within the practice and her dedication to providing the best service for her clients put her above the other finalists. Catherine is not only committed to her professional role of delivering the highest standard of clinical care for her patients and the best service for her clients, but she also devotes a lot of her own time to animal welfare. Catherine is a fantastic role model for her nurses.
VET SUPPORT STAFF OF THE YEAR - Vivienne Jeffs, Arvonia Animal Hospital - Cheltenham, GloucestershireVivienne's reliability, empathy and selflessness really stood out for the judges. Whether it is knowing the name of a pet owner during telephone conversations, or entertaining toddlers in the waiting area, Vivienne is the type of receptionist vet surgeries dream of. The practice would not be the same without her according to those that nominated her.
VET PRACTICE OF THE YEAR - Bridge Veterinary Surgery - Highbridge, SomersetThe practice's hard work and dedication to their clients really impressed the judges. The practice is open 24 hours a day and the dedication the veterinary, with a small practice of only four staff members, it is a particularly well deserved award.
VET PRACTICE MANAGER OF THE YEAR - Cery Lawson-Tankred, Golden Valley Veterinary Hospital - Nailsea, SomersetCery has worked at Golden Valley for over five years, during which time the practice has seen a large degree of upgrade and reinvigoration. Investments made in new equipment and facilities have meant improved care for an expanding array of animals that come through the surgery doors. It was clear to the judges that Cery is the glue that holds the Golden Valley Veterinary Hospital together.
Figures produced by the Royal College of Veterinary Surgeons show that almost half of the first cohort of newly-qualified vets to sign up to the Professional Development Phase (PDP) have now completed it.
The PDP is a web-based database that enables new graduates to develop, and reflect on, their professional skills during their first year in clinical practice. Completing the PDP became a professional obligation for all newly-qualified vets from 2007 onwards. Of the 636 vets who graduated in 2007, 586 (92%) signed up to PDP and 290 have now completed. Of the 616 vets who graduated in 2008, 546 (88%) have so far registered for the PDP.
Freda Andrews, RCVS Head of Education, said: "Undertaking PDP is a professional requirement for every newly-qualified vet working in clinical practice. The first vets to undertake PDP seem to be taking around 15 months from signing up to signing off. Properly completing PDP counts as the first year's CPD and we strongly recommend that this year's graduates sign up as soon as they have found their first clinical role."
The PDP is also open to any vet returning to practice.
To find out more about PDP requirements, log onto www.rcvs.org.uk/pdp, to enrol, email pdp@rcvs.org.uk.
The awards, which which celebrate initiatives that advance the quality of veterinary care and demonstrate a commitment to using an evidence-based approach, will be open for applications until 13th January 2023.
The two new award categories are Antimicrobial Stewardship and Canine Cruciate Outcomes.
The Canine Cruciate Outcome Awards are to recognise and celebrate individuals and teams who are using Quality Improvement initiatives alongside RCVS Knowledge’s Canine Cruciate Registry (CCR) to monitor and improve their canine cruciate surgery outcomes.
Applications are invited by surgeons and teams who are using the CCR.
The Antimicrobial Stewardship Awards, which are divided into farm animal, equine, and companion animal categories, aim to showcase practical examples where individuals and teams are improving responsible antimicrobial prescribing.
In addition, the charity is looking for entries for its existing awards for students and those who have implemented Quality Improvement (QI) techniques.
The Veterinary Evidence Student Awards enables students from around the world to enhance their academic and research skills by writing a Knowledge Summary and submitting it for publication to Veterinary Evidence, RCVS Knowledge's open access, peer-reviewed journal.
The Quality Improvement Awards showcase the implementation of Quality Improvement techniques which drive improvement within the professions.
www.rcvsknowledge.org/awards
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
BlueSky says that conventional treatment for equine sarcoids, which are induced by tumour antigens E6 and E7 of the bovine papillomavirus, have only limited effect and typically result in the recurrence of the tumours.
However, research published by the company in PLoSONE1 showed that sarcoids treated with delNS/E6E7 were completely and permanently eliminated.
For the study, 29 horses were treated with different regimes involving direct injection into the tumours over three years.
Visible and very significant regression of the sarcoids was achieved in 20 of the treated horses, and 100% regression of the sarcoids in 10 equine patients.
Thomas Muster, CEO of BlueSky Immunotherapies said: "The complete elimination of very aggressive and difficult-to-cure equine sarcoids is yet another important proof of the potential offered by our delNS platform."
In addition, the systemic delNS-mediated immune stimulation eliminated non-injected sarcoids and the papillomavirus that caused the sarcoids.
Thomas added: "We are therefore confident that we will also be able to successfully heal and/or eliminate the cervical tumours of the women enrolled in the clinical trials currently under way."
Reference
The sessions will be delivered by Andrew Kent, clinical director at Blaise and a small animal internal medicine specialist, Lara Dempsey, head of soft tissue surgery, Jacques Ferrerira, head of anaesthesia, Mike Farrell, head of orthopaedic surgery, and neurology clinician, Emma Suiter (pictured).
The talks will cover:
Client communication will also be covered, together with some orthopaedics for those with an interest in that area.
Andy said: “We’re building an incredible team at Blaise and are very excited at the prospect of sharing the specialist knowledge that our clinicians have with our wider veterinary community.
"Treating liver conditions can be incredibly complex and our educational programme presents an unrivalled opportunity to deep dive into this part of an animal’s body and how best to approach it.”
Tickets are available for £48 from https://www.ivcevidensiareferrals.com/Delivering-the-Best, with all profits going to the charity StreetVet.
Blaise Veterinary Referral Hospital in Longbridge is IVC’s first purpose-built pet hospital and will be open to accept referral patients from November 2023.
www.blaise-referrals.com
http://herbertsyard.com
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
The RCVS is reminding veterinary surgeons and nurses that there is one week left till the deadline for nominations for the 2012 RCVS and RCVS VN Council elections.
Nominations must be made in writing on the prescribed form and received by the RCVS on or before 31 January 2012.
Prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, manifesto and photograph for inclusion in the RCVS News Extra election specials.
Nobody may nominate more than one candidate, and no current member of the RCVS Council or VN Council may make a nomination.
Full details and guidance notes for both elections are available online from the RCVS Council Election page (www.rcvs.org.uk/rcvscouncil12) and VN Council Election page (www.rcvs.org.uk/vncouncil12).
Nomination forms and candidate information forms for RCVS Council may also be requested from Mrs Gabriella Braun (020 7202 0761 or executiveoffice@rcvs.org.uk) and those for VN Council from Mrs Annette Amato (020 7202 0713 or a.amato@rcvs.org.uk).
Six seats on RCVS Council and two on VN Council are due to be filled in the 2012 elections.
Those elected will take their seats on RCVS Day in July, to serve four-year terms, and will be expected to spend at least six to eight days a year attending Council meetings, working parties and subcommittees (a loss-of-earnings allowance is available).